Vincerx Pharma Inc. (VINC) NASDAQ
$5.06 (1) (-16.50%)
Market Cap: $129.57M
As of 03/28/24 04:00 PM EDT. Market closed.
Vincerx Pharma Inc. (VINC)
NASDAQ
$5.06
(1) (-16.50%)
Market Cap: $129.57M
As of 03/28/24 04:00 PM EDT. Market closed.
vincerx is a clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of ... read more
vincerx is a clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Seelenberger Alexander A. | See Remarks | Aug 11, 2023 | Buy | $0.95 | 10,500 | 9,968 | 30,280 | Aug 14, 2023, 04:09 PM |
Hamdy Ahmed MD | See Remarks | Aug 10, 2023 | Buy | $0.96 | 5,400 | 5,167 | 96,060 | Aug 10, 2023, 06:28 PM |
Hamdy Ahmed MD | See Remarks | Aug 09, 2023 | Buy | $0.95 | 16,900 | 15,994 | 90,660 | Aug 10, 2023, 06:28 PM |
THOMAS TOM C | See Remarks | Aug 10, 2023 | Buy | $0.95 | 5,000 | 4,750 | 219,935 | Aug 10, 2023, 06:28 PM |
Izumi Raquel E. | See Remarks | Aug 10, 2023 | Buy | $0.93 | 3,440 | 3,199 | 85,214 | Aug 10, 2023, 06:27 PM |
Izumi Raquel E. | See Remarks | Aug 09, 2023 | Buy | $0.90 | 13,036 | 11,735 | 81,774 | Aug 10, 2023, 06:27 PM |
Izumi Raquel E. | See Remarks | Dec 14, 2022 | Buy | $0.88 | 28,738 | 25,427 | 68,738 | Dec 14, 2022, 09:22 PM |
Hamdy Ahmed MD | Chief Executive Officer | Dec 14, 2022 | Buy | $0.87 | 35,280 | 30,538 | 73,760 | Dec 14, 2022, 09:22 PM |
THOMAS TOM C | See Remarks | Dec 14, 2022 | Buy | $0.83 | 7,000 | 5,810 | 10,000 | Dec 14, 2022, 09:22 PM |
LOWE CHRISTOPHER P. | Director | Aug 25, 2022 | Buy | $1.65 | 11,600 | 19,139 | 40,000 | Aug 26, 2022, 04:06 PM |
LOWE CHRISTOPHER P. | Director | Aug 24, 2022 | Buy | $1.65 | 18,400 | 30,299 | 28,400 | Aug 26, 2022, 04:06 PM |
Izumi Raquel E. | See Remarks | Jun 27, 2022 | Buy | $1.41 | 40,000 | 56,312 | 40,000 | Jun 29, 2022, 04:05 PM |
Hamdy Ahmed MD | Chief Executive Officer | Jun 23, 2022 | Buy | $1.41 | 24,200 | 34,137 | 38,480 | Jun 27, 2022, 07:20 PM |
Bushnell Laura I. | Director | Jun 09, 2022 | Buy | $1.91 | 15,000 | 28,625 | 19,202 | Jun 13, 2022, 08:01 PM |
THOMAS TOM C | See Remarks | Dec 22, 2021 | Buy | $10.23 | 1,000 | 10,230 | 3,000 | Dec 27, 2021, 04:48 PM |
Hwang Sooin | Chief Business Officer | Dec 23, 2021 | Buy | $10.00 | 3,000 | 30,000 | 390,491 | Dec 27, 2021, 04:42 PM |
Bushnell Laura I. | Director | Dec 22, 2021 | Buy | $10.48 | 2,402 | 25,173 | 4,202 | Dec 27, 2021, 04:39 PM |
Seelenberger Alexander A. | Chief Financial Officer | Dec 22, 2021 | Buy | $10.34 | 2,417 | 24,988 | 12,493 | Dec 27, 2021, 04:34 PM |
Hamdy Ahmed MD | Chief Executive Officer | Dec 22, 2021 | Buy | $10.02 | 6,450 | 64,650 | 14,280 | Dec 27, 2021, 04:28 PM |
Izumi Raquel E. | See Remarks | Aug 04, 2021 | Buy | $11.96 | 1,000 | 11,960 | 1,000 | Aug 06, 2021, 04:45 PM |
Lee John H. | Director | Jun 29, 2021 | Buy | $12.72 | 799 | 10,159 | 799 | Jul 01, 2021, 06:52 PM |
McDonald Andrew I | Director | Jun 29, 2021 | Buy | $12.38 | 20,000 | 247,600 | 20,000 | Jul 01, 2021, 06:05 AM |
Hamdy Ahmed MD | Chief Executive Officer | Jun 29, 2021 | Buy | $12.77 | 7,830 | 99,989 | 7,830 | Jun 30, 2021, 07:02 PM |
Bushnell Laura I. | Director | Jun 30, 2021 | Buy | $12.94 | 1,800 | 23,297 | 1,800 | Jun 30, 2021, 07:02 PM |
Seelenberger Alexander A. | Chief Financial Officer | Jun 29, 2021 | Buy | $12.61 | 7,950 | 100,260 | 7,950 | Jun 30, 2021, 06:59 PM |
LOWE CHRISTOPHER P. | Director | Jun 29, 2021 | Buy | $12.59 | 6,400 | 80,576 | 6,400 | Jun 30, 2021, 06:59 PM |
LOWE CHRISTOPHER P. | Director | Jun 30, 2021 | Buy | $12.66 | 3,600 | 45,576 | 10,000 | Jun 30, 2021, 06:59 PM |
THOMAS TOM C | See Remarks | Jun 29, 2021 | Buy | $12.58 | 2,000 | 25,160 | 2,000 | Jun 30, 2021, 06:57 PM |
Hwang Sooin | Chief Business Officer | Jun 30, 2021 | Buy | $12.66 | 500 | 6,330 | 385,575 | Jun 30, 2021, 06:56 PM |
Owner | Relationship | Date | Value($) |
Seelenberger Alexander A. | See Remarks | 08/11/2023 | 9,968 |
Hamdy Ahmed MD | See Remarks | 08/10/2023 | 5,167 |
Hamdy Ahmed MD | See Remarks | 08/09/2023 | 15,994 |
THOMAS TOM C | See Remarks | 08/10/2023 | 4,750 |
Izumi Raquel E. | See Remarks | 08/10/2023 | 3,199 |
Izumi Raquel E. | See Remarks | 08/09/2023 | 11,735 |
Izumi Raquel E. | See Remarks | 12/14/2022 | 25,427 |
Hamdy Ahmed MD | Chief Executive Officer | 12/14/2022 | 30,538 |
THOMAS TOM C | See Remarks | 12/14/2022 | 5,810 |
LOWE CHRISTOPHER P. | Director | 08/25/2022 | 19,139 |
LOWE CHRISTOPHER P. | Director | 08/24/2022 | 30,299 |
Izumi Raquel E. | See Remarks | 06/27/2022 | 56,312 |
Hamdy Ahmed MD | Chief Executive Officer | 06/23/2022 | 34,137 |
Bushnell Laura I. | Director | 06/09/2022 | 28,625 |
THOMAS TOM C | See Remarks | 12/22/2021 | 10,230 |
Hwang Sooin | Chief Business Officer | 12/23/2021 | 30,000 |
Bushnell Laura I. | Director | 12/22/2021 | 25,173 |
Seelenberger Alexander A. | Chief Financial Officer | 12/22/2021 | 24,988 |
Hamdy Ahmed MD | Chief Executive Officer | 12/22/2021 | 64,650 |
Izumi Raquel E. | See Remarks | 08/04/2021 | 11,960 |
Lee John H. | Director | 06/29/2021 | 10,159 |
McDonald Andrew I | Director | 06/29/2021 | 247,600 |
Hamdy Ahmed MD | Chief Executive Officer | 06/29/2021 | 99,989 |
Bushnell Laura I. | Director | 06/30/2021 | 23,297 |
Seelenberger Alexander A. | Chief Financial Officer | 06/29/2021 | 100,260 |
LOWE CHRISTOPHER P. | Director | 06/29/2021 | 80,576 |
LOWE CHRISTOPHER P. | Director | 06/30/2021 | 45,576 |
THOMAS TOM C | See Remarks | 06/29/2021 | 25,160 |
Hwang Sooin | Chief Business Officer | 06/30/2021 | 6,330 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | 176,020 | 0.00032% | 32.45% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 154,031 | 0.00002% | No change | Other |
BLACKROCK INC. | 64,259 | 0% | No change | Other |
Period of Report: 09/30/2023
10-K/10-Q Filings: View